# Real World Study on the Use of Cemiplimab in Adult Patients in UK

> **NCT05493826** · — · COMPLETED · sponsor: **Sanofi** · enrollment: 110 (actual)

## Conditions studied

- Cutaneous Squamous Cell Carcinoma

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT05493826
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-18
- **Primary completion:** 2022-11-01
- **Final completion:** 2022-11-01
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2023-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05493826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05493826, "Real World Study on the Use of Cemiplimab in Adult Patients in UK". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05493826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*